Abstract
Background
A detailed comprehension of central mechanisms underlying feeding behavior holds considerable promise for the treatment of alimentary disorders.
Methods
In order to elucidate the tight interrelationships occurring at the hypothalamic neuronal endings between aminergic neuro-transmitters and co-localized appetite modulators, we initially studied the effects of two anorexigenic peptides structurally related to thyrotropin-releasing hormone (TRH, 1), namely cyclo(His-Pro) (CHP, 2) and pGlu-His-Gly-OH (3), on [3H]-norepinephrine and [3H]-dopamine release from perfused rat hypothalamic synaptosomes. Furthermore, a number of TRH and CHP analogues were synthesized and tested for their ability to influence neurotransmitter release in the selected neuronal model.
Results
Peptide 3 showed only a slight inhibitory activity on norepinephrine release, whereas no effect was observed for compound 2. TRH analogue 8, metabolically stabilized by the replacement of pyroglutamate with the pyrohomocysteic acid (pHcs), was found to be inactive. Conversely, a significant inhibitory effect on dopamine and norepinephrine release was observed for the CHP-related diketopiperazines cyclo(Leu-Pro) (11) and cyclo(His-Gly) (14).
Conclusions
These results suggest a potential role for cyclo-dipeptides 11 and 14 in the hypothalamic modulation of appetite suppressant circuitry.
Similar content being viewed by others
Abbreviations
- AcOH:
-
acetic acid
- Boc:
-
tert-butoxycarbonyl
- DBU:
-
1,8-diazabicyclo[5.4.0.]undec-7-ene
- DCC:
-
dicyclo-hexylcarbodiimide
- DCM:
-
dichloromethane
- DMF:
-
N,N-dimethylformamide
- AcOEt:
-
ethyl acetate
- Fmoc:
-
9-fluo-renylmethoxycarbonyl
- MeOH:
-
methanol
- NMM:
-
N-methyl-morpholine
- OSu:
-
N-hydroxysuccinimide derivative
- TEA:
-
triethylamine
- TFA:
-
trifluoroacetic acid
- THF:
-
tetrahydrofuran
- Z:
-
benzyloxycarbonyl
References
Bauce LG, Goren HJ: Synthesis of a series of residue 1 (pyroglutamic acid) analogs of thyrotrophin releasing hormone. Int J Pept Protein Res, 1979, 14, 216–226.
Brunetti L, Cacciatore I, Di Stefano A, Duprè S, Giorgi A, Luisi G, Michelotto B et al.: Synthesis and biological evaluation of a novel pyroglutamyl-modified TRH analogue. Farmaco, 2002, 57, 479–486.
Brunetti L, Di Nisio C, Orlando G, Ferrante C, Vacca M: The regulation of feeding: a cross talk between peripheral and central signaling. Int J Immunopathol Pharmacol, 2005, 18, 201–212.
Brunetti L, Michelotto B, Orlando G, Vacca M: Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings. Eur J Pharmacol, 1999, 372, 237–240.
Brunetti L, Orlando G, Ferrante C, Chiavaroli A, Vacca M: Peptide YY (3–36) inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol, 2005, 519, 48–51.
Brunetti L, Orlando G, Michelotto B, Recinella L, Vacca M: Cocaine- and amphetamine-regulated transcript peptide-(55–102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release. Eur J Pharmacol, 2000, 409, 103–107.
Brunetti L, Orlando G, Recinella L, Michelotto B, Ferrante C, Vacca M: Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol, 2004, 493, 41–44.
Calcagni A, Lucente G, Luisi G, Pinnen F, Rossi D: Novel glutathione analogues containing the dithiol and disulfide form of the Cys-Cys dyad. Amino Acids, 1999, 17, 257–265.
Carpino LA, Ionescu D, El-Faham A: Peptide coupling in the presence of highly hindered tertiary amines. J Org Chem, 1996, 61, 2460–2465.
Cummins PM, O’Connor B: Pyroglutamyl peptidase: an overview of the three known enzymatic forms. Biochim Biophys Acta, 1998, 1429, 1–17.
Dietrich MO, HorvathTL: Feeding signals and brain circuitry. Eur J Neurosci, 2009, 30, 1688–1696.
Dutta AS, Morley JS: Polypeptides. Part XIII. Preparation of α-amino-acid (carbazic acid) derivatives and intermediates for the preparation of α-aza-peptides. J Chem Soc Perkin 1, 1975, 17, 1712–1720.
Faden AI, Fox GB, Fan L, Araldi GL, Qiao L, Wang S, Kozikowski AP: Novel TRH analog improves motor and cognitive recovery after traumatic brain injury in rodents. Am J Physiol, 1999, 277, R1196–1204.
Fukuchi I, Asahi T, Kawashima K, Kawashima Y, Yamamura M, Matsuoka Y, Kinoshita K: Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain. Arzneimittelforschung, 1998, 48, 353–359.
Gillard ER, Dang DQ, Stanley BG: Evidence that neuropeptide Y and dopamine in the perifornical hypothalamus interact antagonistically in the control of food intake. Brain Res, 1993, 628, 128–136.
Heuer H, Schäfer MK, Bauer K: The thyrotropin-releasing hormone-degrading ectoenzyme: the third element of the thyrotropin-releasing hormone-signaling system. Thyroid, 1998, 8, 915–920.
Horita A: An update on the CNS actions of TRH and its analogs. Life Sci, 1998, 62, 1443–1448.
Jaworek J, Schally AV, Coy DH, Colaluca J: Effects of analogs of (pyro)Glu-His-Gly-OH on food consumption and gastric acid secretion in rats. Life Sci, 1984, 34, 2597–2603.
Jikihara H, Ikegami H, Koike K, Wada K, Morishige K, Kurachi H, Hirota K et al.: Intraventricular administration of histidyl-proline-diketopiperazine [cyclo(His-Pro)] suppresses prolactin secretion and synthesis: a possible role of cyclo(His-Pro) as dopamine uptake blocker in rat hypothalamus. Endocrinology, 1993, 132, 953–958.
Kaur N, Monga V, Lu X, Gershengorn MC, Jain R: Modifications of the pyroglutamic acid and histidine residues in thyrotropin-releasing hormone (TRH) yield analogs with selectivity for TRH receptor type 2 over type 1. Bioorg Med Chem, 2007, 15, 433–443.
Kelly JA, Scalabrino GA, Slator GR, Cullen AA, Gilmer JF, Lloyd DG, Bennett GW et al.: Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II. Biochem J, 2005, 389, 569–576.
Kow LM, Pfaff DW: Neuropeptides TRH and cyclo(His-Pro) share neuromodulatory, but not stimulatory, action on hypothalamic neurons in vitro: implication for the regulation of feeding. Exp Brain Res, 1987, 67, 93–99.
Lenard NR, Berthoud HR: Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity, 2008, 16, S11–22.
Luisi G, Pinnen F: Synthesis and properties of (S)-isothiazolidine-1,1-dioxide-3-carboxylic acid, anew y-sultam analogue of pyroglutamic acid. Arch Pharm, 1993, 326, 139–141.
Matsui K, Wada K, Kwak S: Ataxia-ameliorating effects of YM-14673, a potent analog of thyrotropin releasing hormone, in ataxic mutant mice. Eur J Pharmacol, 1994, 254, 295–297.
Morley JE, Levine AS, Prasad C: Histidyl-proline dike-topiperazine decreased food intake in rats. Brain Res, 1981, 210, 475–478.
O’Dowd BF, Lee DK, Huang W, Nguyen T, Cheng R, Liu Y, Wang B et al.: TRH-R2 exhibits similar binding and acute signaling but distinct regulation and anatomic distribution compared with TRH-R1. Mol Endocrinol, 2000, 14, 183–193.
Pfleger KD, Kroeger KM, Eidne KA: Receptors for hypothalamic releasing hormones TRH and GnRH: oligo-merization and interactions with intracellular proteins. Semin Cell Dev Biol, 2004, 15, 269–280.
Prasad C: Bioactive cyclic dipeptides. Peptides, 1995, 16, 151–164.
Prokai L, Zharikova AD: Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical braintargeting system. Brain Res, 2002, 952, 268–274.
Reichelt KL, Foss I, Trygstad O, Edminson PD, Johansen JH, Bøler JB: Humoral control of appetite-II. Purification and characterization of an anorexogenic peptide from human urine. Neuroscience, 1978, 3, 1207–1211.
Reichelt WH, Iversen JGH, Paulsen JE, Elgjo K, Reichelt KL: Pyroglutamyl-histidyl-glycine, the endogenous colon mitosis inhibitor, regulates cyclic AMP level in non-tumorigenic colonic epithelial cells. Anticancer Res, 2004, 24, 1465–1468.
Schuhler S, Warner A, Finney N, Bennett GW, Ebling FJ, Brameld JM: Thyrotrophin-releasing hormone decreases feeding and increases body temperature, activity and oxygen consumption in Siberian hamsters. J Neuro-endocrinol, 2007, 19, 239–249.
Shiraishi T: Noradrenergic neurons modulate lateral hypothalamic chemical and electrical stimulation-induced feeding by sated rats. Brain Res Bull, 1991, 27, 347–351.
Simpson KA, Martin NM, Bloom SR: Hypothalamic regulation of food intake and clinical therapeutic applications. Arq Bras Endocrinol Metabol, 2009, 53, 120–128.
Skaric V, Makarevic J, Skaric D: Polyfunctional lysine containing tri- and tetra-peptides. Croat Chem Acta, 1981, 54, 233–240.
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK et al.: Measurement of protein using bicinchoninic acid. Anal Biochem, 1985, 150, 76–85.
Szirtes T, Kisfaludy L, Pálosi E, Szporny L: Synthesis of thyrotropin-releasing hormone analogues. 1. Complete dissociation of central nervous system effects from thyrotropin-releasing activity. J Med Chem, 1984, 27, 741–745.
Wellman PJ, Davies BT, Morien A, McMahon L: Modulation of feeding by hypothalamic paraventricular nucleus α1- and α2-adrenergic receptors. Life Sci, 1993, 53, 669–679.
Yarbrough GG: Fundamental molecular mechanisms of the CNS effects of TRH. Trends Pharmacol Sci, 2003, 24, 617–618.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brunetti, L., Chiavaroli, A., Cocco, A. et al. Synthesis and neuromodulatory effects of TRH-related peptides: inhibitory activity on catecholamine release in vitro. Pharmacol. Rep 65, 823–835 (2013). https://doi.org/10.1016/S1734-1140(13)71063-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S1734-1140(13)71063-6